1
|
Linet MS, Ries LA, Smith MA, Tarone RE and
Devesa SS: Cancer surveillance series: Recent trends in childhood
cancer incidence and mortality in the United States. J Natl Cancer
Inst. 91:1051–1058. 1999. View Article : Google Scholar : PubMed/NCBI
|
2
|
Leavey PJ and Collier AB: Ewing sarcoma:
Prognostic criteria, outcomes and future treatment. Expert Rev
Anticancer Ther. 8:617–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Womer RB, West DC, Krailo MD, Dickman PS,
Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, et
al: Randomized controlled trial of interval-compressed chemotherapy
for the treatment of localized Ewing sarcoma: A report from the
Children's Oncology Group. J Clin Oncol. 30:4148–4154. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
6
|
Tong AW, Fulgham P, Jay C, Chen P, Khalil
I, Liu S, Senzer N, Eklund AC, Han J and Nemunaitis J: MicroRNA
profile analysis of human prostate cancers. Cancer Gene Ther.
16:206–216. 2009.
|
7
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M,
et al: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou P, Jiang W, Wu L, Chang R, Wu K and
Wang Z: miR-301a is a candidate oncogene that targets the homeobox
gene Gax in human hepatocellular carcinoma. Dig Dis Sci.
57:1171–1180. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chen Z, Chen LY, Dai HY, Wang P, Gao S and
Wang K: miR-301a promotes pancreatic cancer cell proliferation by
directly inhibiting Bim expression. J Cell Biochem. 113:3229–3235.
2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shi W, Gerster K, Alajez NM, Tsang J,
Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, et al:
MicroRNA-301 mediates proliferation and invasion in human breast
cancer. Cancer Res. 71:2926–2937. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Miko E, Czimmerer Z, Csánky E, Boros G,
Buslig J, Dezso B and Scholtz B: Differentially expressed microRNAs
in small cell lung cancer. Exp Lung Res. 35:646–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Jones N, Bonnet F, Sfar S, Lafitte M,
Lafon D, Sierankowski G, Brouste V, Banneau G, Tunon de Lara C,
Debled M, et al: Comprehensive analysis of PTEN status in breast
carcinomas. Int J Cancer. 133:323–334. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Mayo LD and Donner DB: The PTEN, Mdm2, p53
tumor suppressor-oncoprotein network. Trends Biochem Sci.
27:462–467. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
18
|
Zeng N, Yang KT, Bayan JA, He L, Aggarwal
R, Stiles JW, Hou X, Medina V, Abad D, Palian BM, et al: PTEN
controls β-cell regeneration in aged mice by regulating cell cycle
inhibitor p16ink4a. Aging Cell. 12:1000–1011. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Li X, Li Z, Li N, Qi J, Fan K, Yin P, Zhao
C, Liu Y, Yao W, Cai X, et al: MAGI2 enhances the sensitivity of
BEL-7404 human hepatocellular carcinoma cells to
staurosporine-induced apoptosis by increasing PTEN stability. Int J
Mol Med. 32:439–447. 2013.PubMed/NCBI
|
20
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Shi Z, Zhang J, Qian X, Han L, Zhang K,
Chen L, Liu J, Ren Y, Yang M, Zhang A, et al: AC1MMYR2, an
inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses
epithelial-mesenchymal transition and suppresses tumor growth and
progression. Cancer Res. 73:5519–5531. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Nelson KM and Weiss GJ: MicroRNAs and
cancer: Past, present, and potential future. Mol Cancer Ther.
7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Ma F, Zhang J, Zhong L, Wang L, Liu Y,
Wang Y, Peng L and Guo B: Upregulated microRNA-301a in breast
cancer promotes tumor metastasis by targeting PTEN and activating
Wnt/β-catenin signaling. Gene. 535:191–197. 2014. View Article : Google Scholar
|
24
|
Dou L, Wang S, Sui X, Meng X, Shen T,
Huang X, Guo J, Fang W, Man Y, Xi J, et al: MiR-301a mediates the
effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by
regulating PTEN expression. Cell Physiol Biochem. 35:1413–1424.
2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Masliah-Planchon J, Pasmant E, Luscan A,
Laurendeau I, Ortonne N, Hivelin M, Varin J, Valeyrie-Allanore L,
Dumaine V, Lantieri L, et al: MicroRNAome profiling in benign and
malignant neurofibromatosis type 1-associated nerve sheath tumors:
Evidences of PTEN pathway alterations in early NF1 tumorigenesis.
BMC Genomics. 14:4732013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Di Cristofano A, De Acetis M, Koff A,
Cordon-Cardo C and Pandolfi PP: Pten and p27KIP1 cooperate in
prostate cancer tumor suppression in the mouse. Nat Genet.
27:222–224. 2001. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Podsypanina K, Ellenson LH, Nemes A, Gu J,
Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE and
Parsons R: Mutation of Pten/Mmac1 in mice causes neoplasia in
multiple organ systems. Proc Natl Acad Sci USA. 96:1563–1568. 1999.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu ZL, Wang H, Liu J and Wang ZX:
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and
chemo- or radio-resistance in non-small cell lung cancer cells by
targeting PTEN. Mol Cell Biochem. 372:35–45. 2013. View Article : Google Scholar
|
29
|
Jiang J, Zhang Y, Yu C, Li Z, Pan Y and
Sun C: MicroRNA-492 expression promotes the progression of hepatic
cancer by targeting PTEN. Cancer Cell Int. 14:952014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kim RJ, Bae E, Hong YK, Hong JY, Kim NK,
Ahn HJ, Oh JJ and Park DS: PTEN loss-mediated Akt activation
increases the properties of cancer stem-like cell populations in
prostate cancer. Oncology. 87:270–279. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Niemeyer BF, Parrish JK, Spoelstra NS,
Joyal T, Richer JK and Jedlicka P: Variable expression of PIK3R3
and PTEN in Ewing Sarcoma impacts oncogenic phenotypes. PLoS One.
10:e01168952015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu
Y, Gu Q, Zhu Z and Liu B: Overexpressed miR-301a promotes cell
proliferation and invasion by targeting RUNX3 in gastric cancer. J
Gastroenterol. 48:1023–1033. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lu Z and Li Y, Takwi A, Li B, Zhang J,
Conklin DJ, Young KH, Martin R and Li Y: miR-301a as an NF-κB
activator in pancreatic cancer cells. EMBO J. 30:57–67. 2011.
View Article : Google Scholar :
|
34
|
Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li
XB, Zhang C and Yang X, Yang ZZ and Yang X: Akt-p53-miR-365-cyclin
D1/ cdc25A axis contributes to gastric tumorigenesis induced by
PTEN deficiency. Nat Commun. 4:25442013. View Article : Google Scholar
|
35
|
Ou Y, Ma L, Ma L, Huang Z, Zhou W, Zhao C,
Zhang B, Song Y, Yu C and Zhan Q: Overexpression of cyclin B1
antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt
pathway in human esophageal squamous cell carcinoma cells. Cancer
Biol Ther. 14:45–55. 2013. View Article : Google Scholar :
|
36
|
Campos M, Kool MM, Daminet S, Ducatelle R,
Rutteman G, Kooistra HS, Galac S and Mol JA: Upregulation of the
PI3K/Akt pathway in the tumorigenesis of canine thyroid carcinoma.
J Vet Intern Med. 28:1814–1823. 2014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zhang Z, Hou X, Shao C, Li J, Cheng JX,
Kuang S, Ahmad N, Ratliff T and Liu X: Plk1 inhibition enhances the
efficacy of androgen signaling blockade in castration-resistant
prostate cancer. Cancer Res. 74:6635–6647. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Li J, Chen Y, Wan J, Liu X, Yu C and Li W:
ABT-263 enhances sorafenib-induced apoptosis associated with Akt
activity and the expression of Bax and p21((CIP1/WAF1)) in human
cancer cells. Br J Pharmacol. 171:3182–3195. 2014. View Article : Google Scholar : PubMed/NCBI
|
39
|
Vadlakonda L, Pasupuleti M and Pallu R:
Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of
G1-S phase of cell cycle in cancer cells. Front Oncol. 3:852013.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Chen ZX, Sang QT, Du YG and Xin YY:
Silence of PTEN in colorectal cancer cells via siRNA inhibits cell
growth. J Environ Pathol Toxicol Oncol. 33:233–237. 2014.
View Article : Google Scholar : PubMed/NCBI
|
41
|
Nishioka C, Ikezoe T, Yang J and Yokoyama
A: Long-term exposure of leukemia cells to multi-targeted tyrosine
kinase inhibitor induces activations of AKT, ERK and STAT5
signaling via epigenetic silencing of the PTEN gene. Leukemia.
24:1631–1640. 2010. View Article : Google Scholar : PubMed/NCBI
|